Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. - Wikidata - wikimedia - TriplyDB

Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

http://www.wikidata.org/entity/Q35007558

about

Stem cell therapy for lower extremity diabetic ulcers: where do we stand?Concise review: therapeutic potential of adipose tissue-derived angiogenic cells Autologous bone marrow cell therapy for peripheral arterial disease Critical limb ischemia: current approach and future directions.Primary progressive multiple sclerosis: progress and challenges.Guanylate-binding protein 1 expression from embryonal endothelial progenitor cells reduces blood vessel density and cellular apoptosis in an axially vascularised tissue-engineered construct.Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial.Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial.Transcatheter Arterial Infusion of Autologous CD133(+) Cells for Diabetic Peripheral Artery Disease.Optimized processing of growth factor mobilized peripheral blood CD34+ products by counterflow centrifugal elutriation.From bench to bedside: review of gene and cell-based therapies and the slow advancement into phase 3 clinical trials, with a focus on Aastrom's Ixmyelocel-T.A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease.Therapeutic strategies for cell-based neovascularization in critical limb ischemia VEGF treatment promotes bone marrow-derived CXCR4+ mesenchymal stromal stem cell differentiation into vessel endothelial cells.Safety and efficacy of autologous cell therapy in critical limb ischemia: a systematic review.Cell transplantation as a pain therapy targets both analgesia and neural repair.Imaging techniques to evaluate cell therapy in peripheral artery disease: state of the art and clinical trials.Vascular injury and repair: a potential target for cell therapies.Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).Biodistribution of locally or systemically transplantedosteoblast-like cells.The role of adult tissue-derived stem cells in chronic leg ulcers: a systematic review focused on tissue regeneration medicine.Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel®, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study.Characterization of the Cellular Output of a Point-of-Care Device and the Implications for Addressing Critical Limb Ischemia.Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia.Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease.Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.Rationale and design of the Clinical and Histologic Analysis of Mesenchymal Stromal Cells in AmPutations (CHAMP) trial investigating the therapeutic mechanism of mesenchymal stromal cells in the treatment of critical limb ischemia.Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results.Role of White Blood Cells in Blood- and Bone Marrow-Based Autologous Therapies

P2860

Q26824484-1D619DC4-B88D-42EF-B463-11A622035B01 Q26998587-DF74AF5E-DEE6-441B-8B1F-23A5FB7CA40B Q27026719-A26E91B3-7CE4-4FAE-A525-83F592F70308 Q30458139-A5B5A69C-50E7-49A0-AE68-DAE2626A0358 Q30590258-4ADB356E-E6AA-4C97-AF2B-17585AE7BAF1 Q34503028-62975E86-A21B-45B0-8AE1-87FB4C0C736D Q34620003-36E5DD8B-A608-4534-A71F-4AC99589219B Q36014060-84473AEF-2D35-4508-B580-3B6CC39CF365 Q36626349-A2588233-01A8-4851-B5AD-8EE7DADA5623 Q36861575-285B67BC-F731-42B7-8454-E5F10CB5593D Q36923569-E68DE686-5A88-4F22-B067-E55EE9930D63 Q37344037-1B547ACC-D88B-4CEC-AE79-DEE4481211AF Q37663453-E72A735F-7F07-470E-8317-B49D3D71ECE8 Q37697685-7B45CB89-7DFB-4D6F-A5D7-E0C1EBBEDE7E Q38001506-080F76DA-A34F-4F60-92B2-29E0D84C9EDE Q38132964-9C987793-CDC1-4F73-A690-1604779FDBDD Q38266756-DB7A7877-2607-4579-80E9-F3980F5F7609 Q38326653-6B36A0AB-B8A4-4BE7-A0E6-CCE30E1A6DF7 Q38380661-6EE7739B-1CBD-4908-9FCA-453DA2E0528D Q38432111-C4C5BC6D-31E0-40C6-86B7-B30171BF5BC7 Q38591798-C2E89A16-89E3-4F26-92A8-C0E50B4E5E67 Q38936941-4B101A37-B0CA-4355-AF26-40293D978D9D Q39234655-5AD75F29-5E15-4CAD-8083-E2E872DB6C99 Q40244927-536E0154-B6BF-4DC8-BC11-E671749E1E17 Q41090665-76D1ADDD-6943-4299-8E08-977F55E3213F Q42181707-1CEB2694-DFD5-4CCE-952E-84BBD2DC5A0D Q42593149-03BC6222-2750-45A8-9E7C-3D46C8B0280A Q50067239-C6801CEA-0C9B-4990-B986-CF88CC44E3DF Q52689443-A8CE24D7-8DC3-4018-9427-554AB2C885F7 Q57176528-83504E5B-7DF7-4DE1-B515-0DADA8E32F4C

P2860

Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

http://www.wikidata.org/entity/Q35007558

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Autologous bone marrow mononuc ...... s with critical limb ischemia.

@ast

Autologous bone marrow mononuc ...... s with critical limb ischemia.

@en

type

label

Autologous bone marrow mononuc ...... s with critical limb ischemia.

@ast

Autologous bone marrow mononuc ...... s with critical limb ischemia.

@en

prefLabel

Autologous bone marrow mononuc ...... s with critical limb ischemia.

@ast

Autologous bone marrow mononuc ...... s with critical limb ischemia.

@en

P1433

Q35007558-59462BD1-EC61-4263-894D-D1FEE56D3528

P1476

Q35007558-16DA190A-37AB-48C2-9D8D-5BC5DEF2AAA1

P2093

Q35007558-05DB5F6C-8B5F-4C6E-ACBE-91B963802FC0

Q35007558-51130379-5CCB-4329-A4D1-C954C2B7C892

Q35007558-51DA15EA-43C1-48F5-9091-E460635A1A2D

Q35007558-7840227A-ABC0-4905-BA97-CE13318388B8

Q35007558-AA9FC727-F68C-4D97-A3CA-91FBB5CC8302

Q35007558-F887C7A1-CBCD-449F-8F61-EB4BE4992FDA

Q35007558-FB940C13-7E6D-402E-AC32-D8FAD78F4D5F

Q35007558-FDDCFDCD-707F-400D-B3F7-7029F3CE16DD

P2860

Q35007558-0376ACC3-6ACB-4901-ACCD-E07F8DDB2678

Q35007558-0418604B-A2D4-4AB1-940F-88C84BF47134

Q35007558-12CFBF80-F530-4E02-87C5-5D84885F044E

Q35007558-19CD58C9-6DDC-4F24-8BE3-5A11116D7033

Q35007558-1E20A912-DD41-4732-9025-20BE4A6B3735

Q35007558-20AD3ED2-93A5-4906-9616-59E2E1253914

Q35007558-2292C463-BA95-42E5-9429-0BC3AF3A98B7

Q35007558-24910D4D-B047-4164-A9D9-888BD3D58EB5

Q35007558-25E5B68A-6F91-4C43-B484-212247456B2B

Q35007558-2EC257B9-FE62-4BBF-AA78-864B50B52D86

P304

Q35007558-AF3D6BDE-2DFF-4B04-B793-C101C4202E81

P31

Q35007558-78821C78-53FA-4E58-AA6C-44A44523B0E3

P356

Q35007558-C96E4B34-4106-40BD-969D-1338F140CA4D

P433

Q35007558-362C5C9B-664B-4336-9536-760D3F6C857A

P478

Q35007558-2FD037D7-703D-483C-B1CC-9103D108097F

P577

Q35007558-9E54E941-B310-4377-90D8-F32E41BA1F73

P5875

Q35007558-8A9F19BD-1A09-4CCC-9AF2-9F412AA9665C

P698

Q35007558-B7A8A838-5898-4EB7-8429-C512A0FB69C6

P921

Q35007558-3F81D1D9-ADA9-4BD0-BAB9-5ED19FF82799

P932

Q35007558-4FDE0F0E-01D6-4AC0-924F-2B74ABAF4AB1

P356

J.JVS.2011.01.074

P1433

Journal of Vascular Surgery

P1476

Autologous bone marrow mononuc ...... s with critical limb ischemia.

@en

P2093

Brian M Rapp

http://www.w3.org/2001/XMLSchema#string

Gary D Hutchins

http://www.w3.org/2001/XMLSchema#string

Janet Klein

http://www.w3.org/2001/XMLSchema#string

Jeffrey H Lawson

http://www.w3.org/2001/XMLSchema#string

Keith L March

http://www.w3.org/2001/XMLSchema#string

Michael C Dalsing

http://www.w3.org/2001/XMLSchema#string

Michael G Wilson

http://www.w3.org/2001/XMLSchema#string

Michael P Murphy

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of putative progenitor endothelial cells for angiogenesis

Augmentation of postnatal neovascularization with autologous bone marrow transplantation.

Regional measurement of canine skeletal muscle blood flow by positron emission tomography with H2(15)O.

Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study.

A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease.

Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.

Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

Predicting which patients will develop chronic critical leg ischemia.

The fate of patients with critical leg ischemia.

P304

1565-74.e1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JVS.2011.01.074

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51071838

http://www.w3.org/2001/XMLSchema#string

P698

21514773

http://www.w3.org/2001/XMLSchema#string

P921

P932

3102148

http://www.w3.org/2001/XMLSchema#string